First quotation
The first quotation took place on 19 July 2005.
Dividend
Neither the General Meeting of the Issuer nor the Meeting of Shareholders of the legal predecessors of the Issuer adopted resolutions on the payment of a dividend.
The policy of the Issuer on the distribution of profit consists in annual allotment of the profit generated by the Company to reserve capital, so as to enhance the position of the Issuer with regard to financing and operation.
Pre-emptive right
Pursuant to Art. 433 § 2 of the Code of Commercial Partnerships and Companies and acting in the interests of the company, existing shareholders entitled to the pre-emptive right to current issues of shares (Series C and D) were divested of this right.
Further issues of shares
| Share series |
Date of issue |
Number of issued shares |
Issue price [PLN] |
Date of registering the issue |
| A* |
29.03.2005
|
1.500.038 |
4,00 |
01.04.2005 |
| B* |
29.03.2005
|
2.500.062 |
4,00 |
01.04.2005 |
| C |
24.07.2005
|
1.500.000 |
7,60 |
29.07.2005 |
| D |
30.01.2007
|
400.000 |
14,50 |
29.03.2007 |
| E |
13.08.2009
|
737.512 |
13,00 |
16.10.2009 |
| F |
14.05.2010 |
500.000 |
21,00 |
02.08.2010 |
| G |
prospectus filed in the KNF, currently in the approval process |
1.189.602 |
- |
- |
* issue related to the merger of the legal predecessors of the Issuer, EuroMediCare Instytut Medyczny Sp. z o.o. and EuroMediCare Serwis Sp. z o.o., on 15 November 2004.The assets of both companies being parties to the merger were transferred, pursuant to Art. 492 § 1 (2), to the Issuer in return for 4,000,100 inscribed preferred Series A shares. Following this, 2,500,062 inscribed preferred Series A shares were converted into ordinary bearer Series B shares.